Ozempic Doses: What You Need to Know for Your Health Journey

Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide treatment begins at low doses and gradually increases over weeks to help your body adapt to the medication. Most patients start at 0.25 mg weekly, with increases every four weeks until reaching an effective maintenance dose, typically between 1.0 and 2.4 mg weekly. Understanding this progression helps set realistic expectations for your weight loss journey.

How Semaglutide Dosing Schedules Work

Semaglutide uses a step-wise titration approach to build tolerance and reduce nausea and digestive side effects. Your starting dose remains at 0.25 mg for your first four weeks, allowing your GLP-1 receptors to activate gradually. Week five introduces a 0.5 mg dose, then 1.0 mg by week nine, and potentially 1.7 or 2.4 mg by weeks thirteen and beyond, depending on your response and tolerance.

This gradual progression differs sharply from starting at full doses, which often triggers significant gastrointestinal discomfort. Clinical studies show that slow titration improves medication adherence and reduces discontinuation rates caused by side effects. Your healthcare provider monitors your tolerance at each stage and may adjust timing based on your individual response.

Semaglutide Dosing and Weight Loss Effectiveness

Research demonstrates that higher semaglutide doses correlate with greater average weight loss over 68 weeks of treatment. Patients at 2.4 mg weekly achieved approximately 17% body weight reduction in clinical trials, while 1.0 mg doses produced roughly 10% weight loss. However, individual results vary considerably based on genetics, lifestyle, metabolism, and adherence.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Managing Side Effects During Dose Increases

Nausea, constipation, and reduced appetite commonly emerge during titration phases, peaking at each new dose level before improving over several days. Slowing your titration schedule—extending intervals between dose increases from four weeks to six or eight weeks—significantly reduces these symptoms. Dietary adjustments including smaller, protein-rich meals and increased hydration support your digestive system as doses climb.

Some patients require doses lower than the standard 2.4 mg maximum to maintain tolerability, and this adjustment does not reduce treatment effectiveness for their individual bodies. Stopping or reducing doses temporarily to manage side effects is medically appropriate and should never cause shame or concern. Your prescribing provider can adjust timing or suggest complementary medications to ease transitions between dose levels.

Semaglutide Dosing Accessibility and PlexusDx Pricing

PlexusDx provides compounded semaglutide injections from licensed 503A compounding pharmacies across all 50 states, at $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of your current dose level. This flat-rate pricing means your cost remains stable whether you begin at 0.25 mg or advance to 2.4 mg, eliminating financial barriers to dose optimization. No insurance, membership fees, or hidden charges apply—HSA and FSA accounts qualify for eligible purchases.

Traditional brand-name semaglutide often carries insurance barriers, prior authorization requirements, and escalating out-of-pocket costs as doses increase. PlexusDx eliminates these obstacles by compounding quality medications at predictable costs, making personalized dosing accessible to more people. After your first month, the optional Precision Peptide Genetic Test ($298) analyzes your GLP-1 receptor and related peptide pathways to guide your prescriber toward your most effective dosing strategy.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What dose of semaglutide should I start with?

Standard initiation begins at 0.25 mg weekly for four weeks to allow your body to adapt. Most patients tolerate this starter dose well with minimal side effects. Your PlexusDx provider will review your health history and metabolism to confirm this starting point is appropriate for you.

How long does it take to reach a full semaglutide dose?

Standard titration reaches therapeutic doses (1.0 to 2.4 mg) within 12 to 16 weeks, though slower progression is an option if you experience side effects. Some patients extend this timeline to 20 or 24 weeks by increasing doses every six to eight weeks instead of every four weeks. Your provider can customize the schedule based on your tolerance and goals.

Does my price increase when my semaglutide dose goes up?

No. PlexusDx charges a flat rate of $189 monthly for compounded semaglutide injections regardless of your dose level—whether you're at 0.25 mg or 2.4 mg. Your dose may need to go up. Your price won't.

What happens if I can't tolerate higher semaglutide doses?

Staying at a lower effective dose is completely appropriate and medically valid—many people achieve excellent results at 1.0 or 1.7 mg weekly. You may also temporarily pause escalation, slow your titration schedule, or add supportive strategies like dietary changes or anti-nausea approaches. Your prescriber works with you to find your personal optimal dose, not the highest possible dose.

Can the Precision Peptide Genetic Test help optimize my semaglutide dosing?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Genetic Testing 101 What You Need To Know Before Getting Tested
• What Genetic Factors Determine How Much Sleep You Need Each Night
• Do You Consume Enough Folate To Maintain Your Health
• Can A Genetic Test Show If I Need More Selenium For Thyroid Health

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.